Other capital market information | 18 August 2025 15:14
Fresenius Medical Care AG
/ Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014
Fresenius Medical Care AG: Share buyback Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014 Share buyback – Interim Report In the period from August 11, 2025 to August 15, 2025 (each inclusive), 996,709 shares were bought back within the framework of the share buyback of Fresenius Medical Care AG, the start of which was disclosed on August 11, 2025 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052. Shares were bought back as follows:
A total of 996,709 shares have been acquired within the framework of this share buyback. The purchase of the shares is carried out by a credit institution commissioned by Fresenius Medical Care AG. Fresenius Medical Care AG will provide regular information regarding the progress of the share buyback, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buy-back/.
18.08.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|
Language: | English |
Company: | Fresenius Medical Care AG |
Else-Kröner-Straße 1 | |
61352 Bad Homburg | |
Germany | |
Internet: | www.freseniusmedicalcare.com |
End of News | EQS News Service |
|
2185328 18.08.2025 CET/CEST